Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

New Zealand’s Covid-19 Vaccine Corporation Secures $3.3 Million In Funding

New Zealand’s most experienced group of vaccine producers, Covid-19 Vaccine Corporation (CVC), has secured $3.3 million in private funding to continue its work on a Covid-19 vaccine for New Zealanders and the world.

CVC was set up in May this year, and utilises well-established New Zealand technology based on tiny, biodegradable biobeads which are coated in small fragments of the COVID-19 virus. CVC has set up multiple collaborations around New Zealand including University of Auckland, Callaghan Innovation at Gracefield and Scion.

“The backing we have from our investors is just extraordinary and so very much appreciated. We could not achieve anything without the cash that is required to progress our Covid-19 vaccine work. I feel the investors are very much part of our team,” says CVC’s Chief Exeutive Officer, Dr Robert Feldman.

The company aims to complete its first human trial of the new vaccine by the end of 2021, which will cost around $8 million.

“We are not aiming to be the first vaccine on the market. Our mission is to produce a superior vaccine that unlike those first off the block, is not created in a rush to reach the market” says Dr Feldman.

“We are taking painstaking measures that are designed to make our vaccine generate an improved response rate while being cost-efficient to produce,” he adds.

The investor group is led by software entrepreneurs Guy and Susie Haddleton, and includes Dr Stephen Strother, the Markon Trust, the CJ and JS Reeve Family Trust and Takapuna Investments.

ABOUT CVC

CVC is made up of a group of lifelong biotech experts:

Dr Robert Feldman - a serial biotech entrepreneur and medical doctor with vaccine experience.

Dr Andy Herbert - a pharmaceutical development and manufacturing expert.

Tara Creaven-Capasso - a regulatory, quality and biotech expert with extensive international experience.

Helen Teale - a global clinical trial management expert.

Jeff Douglas – Managing director of Douglas Pharmaceuticals.

To date, the company has raised a $4.3 million dollars in private company funding, and $488,000 in government funding.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

RNZ: Porirua Most Expensive Region To Rent, According To Trade Me

A rental website shows this town is now New Zealand's most expensive region to rent a house, ahead of Wellington and Auckland cities. More>>

ALSO:


Stats NZ: Nearly 1,000 More Big Businesses Now Than Two Decades Ago – Media Release

There are now 2,690 big businesses in New Zealand employing more than 100 staff – nearly 1,000 or 58 percent more than 20 years ago, Stats NZ said today. Over the 20 years to February 2020, the total number of enterprises in New Zealand increased ... More>>

ALSO:

RNZ: Housing Boom Could Get Worse, Economist Warns

Economists are calling on the Reserve Bank to reinstate lending restrictions, warning the housing market is spiralling out of control. More>>

ALSO:

Westpac: Sets Out Plan To Go Cheque-Free

Westpac NZ has announced details of its plan to phase out cheques, after signalling in May that it would be supporting a move to other forms of payment. Cheques will cease to be available as a means of payment after 25 June 2021. Westpac NZ General ... More>>

ALSO:

NZTA: Major New Zealand Upgrade Programme Projects Go To Tender

Two major New Zealand Upgrade Programme projects are beginning tenders for construction. The New Zealand Upgrade Programme is a $6.8 billion investment to get our cities moving, to save lives and boost productivity in growth areas. The first Auckland ... More>>

Reserve Bank: RBNZ Seeks To Preserve Benefits Of Cash

The Reserve Bank – Te Pūtea Matua is taking on a new role of steward of the cash system “to preserve the benefits of cash for all who need them”, Assistant Governor Christian Hawkesby told the Royal Numismatics Society of New Zealand annual conference ... More>>

ALSO:


CERT NZ: Malicious Computer Virus Targeting New Zealanders

CERT NZ, the government agency which supports organisations and individuals affected by cyber security incidents, says a recent surge of increasingly sophisticated malware attacks is affecting everyday New Zealanders as well as large organisations. The ... More>>

ALSO:

Economy: NZ Small Business Recovery Continues In September

Xero, the global small business platform, today released its Small Business Insights (XSBI) for September revealing an uptick in small business jobs and year-on-year revenue growth in New Zealand. Nationwide, the average number of jobs in the small ... More>>

ALSO:


Courts: Businessman Eric Watson Sentenced To A Four-Month Jail Term

New Zealand businessman Eric Watson has been sentenced to a four-month jail term in the UK for contempt of court, TVNZ reports. More>>

OECD: Area Employment Rate Falls By 4.0 Percentage Points, To 64.6% In Second Quarter Of 2020

The OECD area employment rate – the share of the working-age population with jobs – fell by 4.0 percentage points, to 64.6%, in the second quarter of 2020, its lowest level since the fourth quarter of 2010. Across the OECD area, 560 million persons ... More>>

Spark: Turns On 5G In Auckland And Offers A Glimpse Into The Future Of Smart Cities

Spark turned on 5G in downtown Auckland today and has partnered with Auckland Transport (AT) to showcase some of the latest in IoT (Internet of Things) technology and demonstrate what the future could look like for Auckland’s CBD with the power of 5G. 5G is ... More>>

Stats NZ: Monthly Migration Remains Low

Since the border closed in late-March 2020, net migration has averaged about 300 a month, Stats NZ said today. In the five months from April to August 2020, overall net migration was provisionally estimated at 1,700. This was made up of a net gain ... More>>